Analytical Overview: AbCellera Biologics Inc (ABCL)’s Ratios Tell a Financial Story

Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

As of close of business last night, AbCellera Biologics Inc’s stock clocked out at $2.89, up 5.86% from its previous closing price of $2.73. In other words, the price has increased by $5.86 from its previous closing price. On the day, 3.63 million shares were traded. ABCL stock price reached its highest trading level at $2.9 during the session, while it also had its lowest trading level at $2.72.

Ratios:

To gain a deeper understanding of ABCL’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.96 and its Current Ratio is at 10.96. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.06.

Upgrades & Downgrades

On February 22, 2024, The Benchmark Company Upgraded its rating to Buy which previously was Hold but kept the price unchanged to $9.

On December 05, 2023, KeyBanc Capital Markets started tracking the stock assigning a Overweight rating and target price of $6.KeyBanc Capital Markets initiated its Overweight rating on December 05, 2023, with a $6 target price.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ABCL now has a Market Capitalization of 851584704 and an Enterprise Value of 253281392. For the stock, the TTM Price-to-Sale (P/S) ratio is 25.76 while its Price-to-Book (P/B) ratio in mrq is 0.77. Its current Enterprise Value per Revenue stands at 7.663 whereas that against EBITDA is -1.18.

Stock Price History:

Over the past 52 weeks, ABCL has reached a high of $6.05, while it has fallen to a 52-week low of $2.34. The 50-Day Moving Average of the stock is 10.04%, while the 200-Day Moving Average is calculated to be -19.91%.

Shares Statistics:

It appears that ABCL traded 1.89M shares on average per day over the past three months and 1738550 shares per day over the past ten days. A total of 290.82M shares are outstanding, with a floating share count of 206.59M. Insiders hold about 29.89% of the company’s shares, while institutions hold 33.37% stake in the company. Shares short for ABCL as of 1728950400 were 17353101 with a Short Ratio of 9.17, compared to 1726185600 on 16835591. Therefore, it implies a Short% of Shares Outstanding of 17353101 and a Short% of Float of 7.6499999999999995.

Most Popular